Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.

Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.

Many mechanisms have been proposed to explain why immune responses against human tumor antigens are generally ineffective. For example, tumor cells have been shown to develop active immune evasion mechanisms. Another possibility is that tumor antigens are unable to optimally stimulate tumor-specific...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون:	Valmori, D, Fonteneau, J, Valitutti, S, Gervois, N, Dunbar, R, Liénard, D, Rimoldi, D, Cerundolo, V, Jotereau, F, Cerottini, J, Speiser, D, Romero, P
التنسيق:	Journal article
اللغة:	English
منشور في:	1999

مواد مشابهة

Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376.
حسب: Valmori, D, وآخرون
منشور في: (1999)

Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
حسب: Valmori, D, وآخرون
منشور في: (2000)

An antigen-targeted approach to adoptive transfer therapy of cancer.
حسب: Valmori, D, وآخرون
منشور في: (1999)

Ex vivo staining of metastatic lymph nodes by class I major histocompatibility complex tetramers reveals high numbers of antigen-experienced tumor-specific cytolytic T lymphocytes.
حسب: Romero, P, وآخرون
منشور في: (1998)

Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3.
حسب: Valmori, D, وآخرون
منشور في: (1999)

High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals.
حسب: Pittet, M, وآخرون
منشور في: (1999)

In vivo expression of natural killer cell inhibitory receptors by human melanoma-specific cytolytic T lymphocytes.
حسب: Speiser, D, وآخرون
منشور في: (1999)

CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients.
حسب: Speiser, D, وآخرون
منشور في: (1999)

Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients.
حسب: Valmori, D, وآخرون
منشور في: (2000)

Immune monitoring in cancer immunotherapy.
حسب: Romero, P, وآخرون
منشور في: (2000)

Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL.
حسب: Chen, J, وآخرون
منشور في: (2000)

The efficiency of antigen recognition by CD8+ CTL clones is determined by the frequency of serial TCR engagement.
حسب: Hudrisier, D, وآخرون
منشور في: (1998)

Tumor cell recognition efficiency by T cells.
حسب: Daniel E Speiser, وآخرون
منشور في: (2005-03-01)

Double positive CD4CD8 alphabeta T cells: a new tumor-reactive population in human melanomas.
حسب: Juliette Desfrançois, وآخرون
منشور في: (2010-01-01)

Quantitating T cell cross-reactivity for unrelated peptide antigens.
حسب: Ishizuka, J, وآخرون
منشور في: (2009)

1379 Novel backbone-modified analogues of antigenic peptides improve immunogenic capabilities of anti-tumor peptide vaccines
حسب: Douglas McNeel, وآخرون
منشور في: (2023-11-01)

Antigen presentation. Naturally processed peptides.
حسب: Elliott, T, وآخرون
منشور في: (1990)

The efficiency of antigen recognition by CTL is determined by the frequency of serial TCR engagement.
حسب: Hudrisier, D, وآخرون
منشور في: (1998)

Antigenic reactivity of peptides derived from wheat gluten with sera from patients with coeliac disease.
حسب: Rawcliffe, P, وآخرون
منشور في: (1985)

Use of fluorogenic histocompatibility leukocyte antigen-A*0201/HPV 16 E7 peptide complexes to isolate rare human cytotoxic T-lymphocyte-recognizing endogenous human papillomavirus antigens.
حسب: Youde, S, وآخرون
منشور في: (2000)

Effects of epitope modification on T cell receptor-ligand binding and antigen recognition by seven H-2Kd-restricted cytotoxic T lymphocyte clones specific for a photoreactive peptide derivative.
حسب: Kessler, B, وآخرون
منشور في: (1997)

Dependence of T cell antigen recognition on T cell receptor-peptide MHC confinement time.
حسب: Aleksic, M, وآخرون
منشور في: (2010)

Using modified antigenic sequences to develop cancer vaccines: are we losing the focus?
حسب: Danila Valmori, وآخرون
منشور في: (2004-11-01)

Reactivity of sulfonylbutadienes. Synthesis of Ginsenol analogues
حسب: David Diez, وآخرون
منشور في: (2010-10-01)

A tumor-binding antibody with cross-reactivity to viral antigens
حسب: Michael J. Campa, وآخرون
منشور في: (2025-02-01)

Tumor defense by murine cytotoxic T cells specific for peptide bound to nonclassical MHC class I.
حسب: Griffiths, E, وآخرون
منشور في: (1998)

High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence
حسب: Laura Carretero-Iglesia, وآخرون
منشور في: (2020-01-01)

Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells.
حسب: Larsson, M, وآخرون
منشور في: (2000)

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.
حسب: André, P, وآخرون
منشور في: (1998)

Synthesis and reactivity of novel gamma-phosphate modified ATP analogues.
حسب: Lee, SE, وآخرون
منشور في: (2009)

Synthesis and reactivity of novel γ-phosphate modified ATP analogues
حسب: Lee, SE, وآخرون
منشور في: (2009)

Synthesis of a novel analogue of peptide ProGlyPro
حسب: A. V. Baranov, وآخرون
منشور في: (2006-12-01)

Identifying individual T cell receptors of optimal avidity for tumor antigens
حسب: Michaël eHebeisen, وآخرون
منشور في: (2015-11-01)

IMMUNOMODULATORY ACTIVITY OF ANTIMICROBIAL PEPTIDE INDOLICIDIN AND ITS STRUCTURAL ANALOGUES
حسب: A. Yu. Artamonov, وآخرون
منشور في: (2014-07-01)

363 Identification of dark antigen® reactive T cell receptors from tumor-infiltrating lymphocytes
حسب: Özcan Met, وآخرون
منشور في: (2023-11-01)

Peptide modification or blocking of CD8, resulting in weak TCR signaling, can activate CTL for Fas- but not perforin-dependent cytotoxicity or cytokine production.
حسب: Kessler, B, وآخرون
منشور في: (1998)

Targeting an alternate Wilms' tumor antigen 1 peptide bypasses immunoproteasome dependency
حسب: Lahman, MC, وآخرون
منشور في: (2022)

Tumor-Specific CircRNA-Derived Antigen Peptide Identification for Hepatobiliary Tumors
حسب: Wenwen Wang, وآخرون
منشور في: (2023-03-01)

Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class I-restricted presentation.
حسب: Smith, D, وآخرون
منشور في: (2002)

Self antigens expressed by solid tumors Do not efficiently stimulate naive or activated T cells: implications for immunotherapy.
حسب: Speiser, D, وآخرون
منشور في: (1997)